DeepMed Research

INSTITUTE OF LIVER AND BILIARY SCIENCES

🇮🇳India

Country: 🇮🇳India

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

'Tenofovir Pulse and Peg Interferon Alpha 2b' Therapy in HBeAg-positive Patients With Normal ALT

Not Applicable

Withdrawn

Conditions: HBV

Interventions: Drug: Tenofovir + Interferon alpha 2b
Drug: Tenofovir disoproxil Fumarate

First Posted Date: 2015-05-27

Last Posted Date: 2018-02-08

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Registration Number: NCT02454764

Locations: 🇮🇳
Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

THE IMMUNOLOGICAL EFFECTS AND METABOLIC TOLERANCE OF LIPID INFUSION IN PATIENTS WITH CIRRHOSIS.

Not Applicable

Completed

Conditions: Alcoholic Liver Disease

Interventions: Dietary Supplement: Soybean based lipid emulsion

First Posted Date: 2015-03-06

Last Posted Date: 2016-09-12

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 55

Registration Number: NCT02381769

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Effect of Goal Directed Ammonia Lowering Therapy in Acute on Chronic Liver Failure Patients With Hepatic Encephalopathy.

Not Applicable

Completed

Conditions: Acute-On-Chronic Liver Failure

Interventions: Drug: Lactulose + Rifaximin
Drug: Lactulose

First Posted Date: 2014-12-22

Last Posted Date: 2018-02-08

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 73

Registration Number: NCT02321371

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Assessment of Coagulation Profile and Haematopoietic Responses in Patients With Acute-on-chronic Liver Failure During Systemic Inflammatory Response (SIRS) and Sepsis

Completed

Conditions: Acute on Chronic Liver Failure

Interventions: Other: Sonoclot/TEG test

First Posted Date: 2014-12-04

Last Posted Date: 2018-02-08

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 114

Registration Number: NCT02307409

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Therapeutic Approach to Diastolic Dysfunction in Chronic Liver Disease Patients and Its Impact on Morbidity and Mortality

Not Applicable

Completed

Conditions: Chronic Liver Disease
Diastolic Dysfunction

Interventions: Procedure: Endoscopic Variceal Ligation
Drug: Carvedilol
Drug: Ivabradine

First Posted Date: 2014-11-19

Last Posted Date: 2018-02-08

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 189

Registration Number: NCT02294292

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related Parkinsonism

Not Applicable

Completed

Conditions: Cirrhosis Related Parkinsonism

Interventions: Drug: Lactulose+Rifaximin +Bromocriptine

First Posted Date: 2014-10-16

Last Posted Date: 2016-11-22

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 50

Registration Number: NCT02265484

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Sorafenib Plus Vitamin K1 Versus Sorafenib in Advanced Hepatocellular Carcinoma

Not Applicable

Completed

Conditions: Hepatocellular Carcinoma

Interventions: Drug: Sorafenib 400mg twice daily + intravenous infusion ofVit K1
Drug: Sorafenib 400 mg twice daily + Intravenousinfusion of placebo

First Posted Date: 2014-10-08

Last Posted Date: 2019-10-28

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 60

Registration Number: NCT02259647

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Effect of Metformin on Disease Progression in Patients With Cryptogenic Cirrhosis (NASH-related Cirrhosis) With Diabetes or Impaired Glucose Tolerance or Insulin Resistance

Not Applicable

Completed

Conditions: NASH Related Cirrhosis

Interventions: Drug: Insulin
Drug: Metformin

First Posted Date: 2014-09-09

Last Posted Date: 2018-02-08

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 86

Registration Number: NCT02234440

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

The Efficacy of S-adenosyl Methionine (SAMe) Versus Pentoxiphylline in Patients With Non-alcoholic Steatohepatitis With Fibrosis

Not Applicable

Completed

Conditions: Non-alcoholic Steatohepatitis

Interventions: Drug: pentoxiphylline (PTX)
Drug: S-adenosylmethionine (SAMe)

First Posted Date: 2014-09-04

Last Posted Date: 2019-10-29

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 122

Registration Number: NCT02231333

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Long Term Effect of Aggressive Nutritional Management on Survival in Patients With Alcoholic Liver Disease

Not Applicable

Completed

Conditions: Alcoholic Liver Disease

Interventions: Dietary Supplement: Polymeric nutritional supplements
Dietary Supplement: Standard Nutrional Treatment

First Posted Date: 2014-05-16

Last Posted Date: 2016-02-11

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 147

Registration Number: NCT02140294

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy